MarketCap
Facebook
X
TelegramQuartalsbericht 2024-Q3
hinzugefügt 07.11.2024
BIOLASE Langfristige Verbindlichkeiten 2011-2026 | BIOL
Langfristige Verbindlichkeiten Jährlich BIOLASE
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 5.69 M | 11.5 M | 354 K | 1.86 M | 2.22 M | 1.2 M | 618 K | 804 K | 956 K |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 11.5 M | 354 K | 2.8 M |
Langfristige Verbindlichkeiten anderer Aktien in der Medizinische Geräte
| Name | Langfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Align Technology
ALGN
|
184 M | $ 186.15 | 3.03 % | $ 13.9 B |  USA |
 |
Alphatec Holdings
ATEC
|
89.9 M | $ 11.57 | 2.84 % | $ 1.74 B | USA |
 |
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | USA |
 |
AxoGen
AXGN
|
1.61 M | $ 34.98 | 4.51 % | $ 1.61 B | USA |
 |
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
44 M | - | -26.83 % | $ 2.62 M | USA |
 |
EDAP TMS S.A.
EDAP
|
7.44 M | $ 3.33 | 0.15 % | $ 125 M |  France |
 |
AdaptHealth Corp.
AHCO
|
424 M | $ 12.54 | 1.78 % | $ 1.69 B | USA |
 |
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
1.35 B | $ 292.47 | 1.49 % | $ 8.25 B | USA |
 |
Cytosorbents Corporation
CTSO
|
14 M | $ 0.57 | -2.41 % | $ 35.5 M | USA |
 |
Inogen
INGN
|
52.5 M | $ 6.45 | - | $ 172 M | USA |
 |
IRIDEX Corporation
IRIX
|
2.33 M | $ 1.03 | - | $ 17.4 M | USA |
 |
Bruker Corporation
BRKR
|
1.28 B | $ 40.21 | 2.97 % | $ 5.99 K | USA |
 |
Boston Scientific Corporation
BSX
|
11.8 B | $ 64.38 | 1.9 % | $ 95.3 B | USA |
 |
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
28.3 M | - | 0.15 % | $ 844 M | USA |
 |
LENSAR
LNSR
|
3.44 M | $ 5.98 | 1.01 % | $ 71.5 M | USA |
 |
ClearPoint Neuro
CLPT
|
23.9 M | $ 10.28 | 2.7 % | $ 291 M | USA |
 |
Dynatronics Corporation
DYNT
|
10 M | - | 14.99 % | $ 929 K | USA |
 |
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | USA |
 |
Electromed
ELMD
|
8.87 K | $ 25.14 | 0.76 % | $ 213 M | USA |
 |
Myomo
MYO
|
275 K | $ 0.75 | 3.23 % | $ 31.4 M | USA |
 |
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | USA |
 |
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | USA |
 |
Sintx Technologies
SINT
|
1.76 M | $ 2.95 | 0.4 % | $ 8.18 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
8.24 M | - | - | $ 111 M |  Canada |
 |
Globus Medical
GMED
|
18.2 M | $ 95.0 | 2.17 % | $ 12.8 B | USA |
 |
Stryker Corporation
SYK
|
13 B | $ 351.25 | 1.15 % | $ 134 B | USA |
 |
Tactile Systems Technology
TCMD
|
14.1 M | $ 24.87 | 2.6 % | $ 569 M | USA |
 |
Helius Medical Technologies
HSDT
|
252 K | $ 2.03 | - | $ 1.23 M | USA |
 |
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | USA |
 |
TransMedics Group
TMDX
|
34.5 M | $ 116.53 | 2.8 % | $ 3.96 B | USA |
 |
Tandem Diabetes Care
TNDM
|
31.7 M | $ 20.62 | 2.59 % | $ 1.4 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
116 M | $ 17.45 | 2.95 % | $ 409 M | USA |
 |
Delcath Systems
DCTH
|
2.52 M | $ 10.71 | 2.49 % | $ 384 M | USA |
 |
Inspire Medical Systems
INSP
|
24.6 M | $ 55.0 | 0.15 % | $ 1.62 B | USA |